International Drug Development Association
		SEARCH	[Advanced Search] [Home]
IAGIM ONLINE

DRAFT FDA GUIDELINES - IAGIM REVIEWED

BACK TO INDEX

Guideline - #1 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Impurities in New Drug Products - Q3B(R)

Guideline - #2 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. BA and BE Overview - General Considerations

Guideline - #3 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Impurities in New Drug Substances - Q3A(R)

Guideline - #4 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now.

Guideline - #5 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now.

Guideline - #6 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. Fax Amendments

Guideline - #7 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. Alternative Active Suppliers

Guideline - #8 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. August

Guideline - #9 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. September

Guideline - #10 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. October

Guideline - #11 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now. November

Guideline - #12 FDA Draft Guidelines for Generic & Innovative Drugs Reviewed by IAGIM Scientific Committee. Download FDA/Journal Guide Now December